Tri-Sodium Citrate Locking Solution Suppliers & Bulk Manufacturers
Available Forms: Sterile Solution
Available Strengths: 4% , 30%
Reference Brands: Citra-Lock, CitraFlow (US & EU)
Category: Nephrology
Tri-Sodium Citrate Locking Solution is available in Sterile Solution and strengths such as 4% , 30%. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tri-Sodium Citrate Locking Solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tri-Sodium Citrate Locking Solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Tri-Sodium Citrate Locking Solution is a catheter lock used in hemodialysis to maintain central venous catheter patency and prevent clot formation. Commonly used in nephrology care, it serves as a safe alternative to heparin, especially in patients at risk for heparin-induced complications. With both anticoagulant and antimicrobial properties at higher concentrations (e.g., 46.7%), it ensures effective catheter maintenance between dialysis sessions. Marketed under various brands in the US and EU, it is widely used in hospitals and dialysis clinics. Ideal for pharmaceutical distributors, Tri-Sodium Citrate Locking Solution is available for bulk supply through trusted Pharma B2B export partners.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Bumetanide
Strength:
0.5 mg, 1 mg, 2 mg, 0.25 mg/mL
Form: Tablet / Injection
Reference Brands: Bumex (USA), Burinex(EU)
View DetailsAcetazolamide
Strength:
250 mg, 500 mg, 500 mg/10 mL
Form: Tablets/ capsules/ Injectable
Reference Brands: Diamox (USA/EU)
View DetailsSevelamer Hydrochloride
Strength:
400 mg, 800 mg
Form: Tablet
Reference Brands: Renagel (USA),
View DetailsMetolazone
Strength:
2.5 mg, 5 mg, and 10 mg
Form: Tablets
Reference Brands: Zaroxolyn (US), Zytanix (EU), Metoz (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers